Rebecca A O'Brien from Cottage Grove, OR, age 63

Us Patents

Use Of Soluble Gammadelta T Cell Receptors For Regulating T Cell Function
view source
US Patent:

20030175212, Sep 18, 2003
Filed:

Jan 10, 2003
Appl. No.:

10/340536
Inventors:

Rebecca O'Brien - Denver CO, US
Willi Born - Denver CO, US
Christina Roark - Highlands Ranch CO, US
M. Aydintug - Thornton CO, US
International Classification:

A61K038/17
A61L009/04
US Classification:

424/045000, 514/012000
Abstract:

Disclosed is a method of using soluble T cell receptors to regulate a T cell-mediated immune response in a mammal.

Use Of Soluble Gammadelta Cell Receptors For Regulating T Cell Function
view source
US Patent:

20070269426, Nov 22, 2007
Filed:

Apr 3, 2007
Appl. No.:

11/695986
Inventors:

Rebecca O'Brien - Denver CO, US
Willi Born - Denver CO, US
Christina Roark - Highlands Ranch CO, US
M. Aydintug - Thornton CO, US
Assignee:

NATIONAL JEWISH MEDICAL AND RESEARCH CENTER - Denver CO
International Classification:

A61K 39/395
US Classification:

424131100
Abstract:

Disclosed is a method of using soluble γδ T cell receptors to regulate a γδ T cell-mediated immune response in a mammal.

Gamma Delta T Cells And Methods Of Treatment Of Interleukin-17 Related Conditions
view source
US Patent:

20080248025, Oct 9, 2008
Filed:

Mar 21, 2008
Appl. No.:

12/053310
Inventors:

Christina Roark - Englewood CO, US
Rebecca L. O'Brien - Denver CO, US
Willi K. Born - Denver CO, US
Assignee:

NATIONAL JEWISH MEDICAL AND RESEARCH CENTER - Denver CO
International Classification:

A61K 39/395
A61K 38/17
C12Q 1/02
A61P 35/00
A61P 37/00
US Classification:

4241301, 514 12, 435 29
Abstract:

This invention generally relates to methods to treat conditions and diseases associated with interleukin-17 (IL-17) production. The invention also relates to methods of inhibiting γδ T cells, and particularly, a subset of γδ T cells that produce IL-17.

Agents And Methods For Inhibition Of Airway Hyperresponsiveness
view source
US Patent:

20090028849, Jan 29, 2009
Filed:

Jul 24, 2008
Appl. No.:

12/178923
Inventors:

Rebecca L. O'Brien - Denver CO, US
Willi K. Born - Denver CO, US
Niyun Jin - Denver CO, US
Christina L. Roark - Englewood CO, US
International Classification:

A61K 39/395
A61K 38/17
A61P 11/00
US Classification:

4241301, 514 12, 424 9371
Abstract:

The present invention provides methods and compositions for inhibition of Airway Hyperresponsiveness (“AHR”) by deleting, inactivating or inhibiting a subset of innate γδ T cells, alone or in conjunction with the inhibition of Natural Killer T (“NKT”) cells. The methods comprise selective leukophoresis to remove the γδ T cells from the individual's blood or administration of an agent that selectively targets and inhibits or inactivates the γδ T cells. The methods of the present invention can be used to treat AHR in a variety of different ailments, including allergen-induced conditions or respiratory conditions and diseases.

Lawyers & Attorneys

Rebecca O'Brien - Lawyer

view source

Office:

O'Brien Cavanagh Ivanova LLP

Specialties:

Corporate & Incorporation

ISLN:

1000498978

Admitted:

2004

Law School:

University of California at Berkeley, Boalt Hall School of Law, JD - Juris Doctor, 2004

Resumes

Clinical Improvement Coach

view source

Industry:

Hospital & Health Care

Work:

Healthcare Association of Hawaii
Clinical Improvement Coach
Hhsc Kauai Region May 2009 - Jan 2016
Director of Quality
Kauai Veterans Memorial Hosp St Francis Home Care Services May 1993 - May 2009
Registered Nurse

Certifications:

Certified Professional of Healthcare Quality
Cphq